Posts: 39

Suresh PDMR

Latest Posts by the Author

  1. Response regression model as a guiding principle for pharmacological mechanistic investigation of host-targeted antivirals
  2. Discovery of vina-ginsenoside R18 as a novel dual-target inhibitor of dengue virus envelope protein and RNA-dependent RNA polymerase
  3. Benzo-fused ten-membered ring meroterpenoids: sources, chemical diversity, biological activities, and biosynthesis
  4. Biologically Active Guanidine Alkaloids
  5. Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus
  6. Caryota maxima leaf extract extends Caenorhabditis elegans lifespan by inducing mono-unsaturated fatty acid accumulation via DAF-2 signaling
  7. Advances in gasdermin activation, regulation, and targeted drug development
  8. Formulation approaches and strategies for transdermal delivery of insulin: special emphasis on microneedle-based systems
  9. Therapeutic strategies targeting SREBP transcription factors
  10. Catapol: a promising natural neuroprotective agent for neurologic disorders
  11. PROTACs improve selectivity for targeted proteins
  12. Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance
  13. Revolutionizing HIV treatment: unveiling the new frontiers of HIV capsid research
  14. Discovery of wedelolactone from Eclipta Prostrata (L.) Linn. as a natural PDE4 inhibitor with potent anti-psoriasis effects
  15. Boosting pancreatic cancer chemotherapy by disrupting nerve–cancer crosstalk
  16. Moracin M derivative targeting PDE4 for the treatment of psoriasis
  17. Berberine inhibits phagocytosis through the TLR4-PI3K-CDC42 pathway
  18. Natural supramolecular photosensitizer with in situ switchable photothermal/photodynamic effects as an imaging platform for precise and controlled cancer synergistic therapy
  19. Coumarin derivatives as inhibitors against monoamine oxidase: structure-activity relationships and inhibitory mechanisms
  20. Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong